ADHD is a complex neurodevelopmental condition that affects people of all ages, impacting their ability to focus, control impulses and regulate energy. While medication and behavioral therapy have helped many, there is growing interest in approaches that complement — or in some cases reduce reliance on — conventional methods. One of the most promising is neurofeedback.
Understanding neurofeedback
Neurofeedback, also known as EEG biofeedback, is a non-invasive intervention that uses real-time monitoring of brainwave activity to help people gain more control over their own neural functioning. Sensors measure brainwave patterns, the person receives immediate feedback, and over many sessions the brain learns to shift toward healthier patterns through practice and reinforcement.
How neurofeedback can help with ADHD
Research has shown that people with ADHD often exhibit distinct patterns of brainwave activity, particularly in the regions responsible for attention, impulse control and executive functioning. Neurofeedback targets those patterns, aiming to normalize brainwave activity through operant conditioning. By reinforcing healthier patterns, it seeks to ease ADHD symptoms and improve overall cognitive functioning.
The evidence — updated 2026
ADHD is the most-studied use of neurofeedback, with trials going back to 1976. For the standard protocols — theta/beta, sensorimotor rhythm and slow cortical potentials — the evidence is strong. Meta-analyses find medium-to-large improvements in inattention and impulsivity, and a follow-up meta-analysis found those gains hold or grow six to twelve months after training ends, while children in non-active control groups lost theirs. In 2020 an international review applied a stricter version of the American Psychological Association’s criteria and rated standard-protocol neurofeedback a well-established treatment for ADHD, with remission rates of 32–47%.
The debate that remains is about generic, one-size-fits-all neurofeedback. A 2025 meta-analysis in JAMA Psychiatry pooled 38 trials of every kind of protocol and found no meaningful improvement on blinded ratings overall — but a significant benefit in the trials that used established standard protocols. We link to all of it on our research page, because it argues for what we do: standard protocols, chosen from an individual qEEG brain map, which is the precision approach the review’s authors call for.
If you want to go deeper, the ISNR Comprehensive Bibliography of Neurofeedback Research has a dedicated ADD/ADHD section, and ISNR’s open-access journal NeuroRegulation publishes new ADHD neurofeedback studies every year.
Complementing other treatments
Neurofeedback is best viewed as a complement to existing ADHD care rather than a replacement. Many families find it a valuable addition — sometimes reducing reliance on medication, sometimes enhancing the effects of other strategies. Because it is non-invasive and free of the side effects associated with some medications, it appeals to families looking for personalized options. Any change to medication should always be made with the prescribing doctor.
Why professional guidance matters
Neurofeedback should be administered by qualified practitioners who can tailor protocols to each person’s brain. That starts with a qEEG brain map, which shows the actual pattern we’re training rather than a generic protocol.
Looking ahead
As our understanding of neuroplasticity grows, neurofeedback is poised to play an increasingly significant role in comprehensive ADHD care. For families who want a drug-free, personalized option, it represents a compelling path — and one that can now be done at home with clinical supervision.
This article is for education only and is not medical advice. Neurofeedback supports self-regulation; it does not diagnose, treat or cure any condition.